Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianle Hu

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Environmental Pollution (Barking, Essex : 1987)|May 6, 2024
Subchronic co-exposure of polystyrene nanoplastics and 3-BHA significantly aggravated the reproductive toxicity of ovaries and uterus in female miceGuanghua Xiong, Haiyan Zhang, Yulin Peng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2016
A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced CancerLee S Rosen, Jonathan W Goldman, Alain P Algazi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 29, 2025
TIP25-243: Randomized Study Evaluating Optimal Dose, Efficacy and Safety of E7386 + Lenvatinib Versus Treatment of Physicians' Choice in Advance/Recurrent Endometrial Carcinoma Previously Treated With Anti-PD-(L)1 ImmunotherapyRamez Eskander, Jung-Yun Lee, Mansoor Mirza, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 3, 2025
Randomized study evaluating optimal dose, efficacy, and safety of E7386 plus lenvatinib versus treatment of physician's choice in advanced/recurrent endometrial carcinoma previously treated with platinum-based chemotherapy and immune checkpoint inhibitorsRamez N Eskander, Jung-Yun Lee, Mansoor Raza Mirza, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Rejoinder to Letter to the Editor "The Hazards of Period Specific and Weighted Hazard Ratios"Ray S Lin, Ji Lin, Satrajit Roychoudhury, et al.
Science (New York, N.Y.)|April 28, 2007
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variantsLaura J Scott, Karen L Mohlke, Lori L Bonnycastle, et al.
Nature Genetics|April 1, 2008
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetesEleftheria Zeggini, Laura J Scott, Richa Saxena, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Environmental Pollution (Barking, Essex : 1987)|May 6, 2024
Subchronic co-exposure of polystyrene nanoplastics and 3-BHA significantly aggravated the reproductive toxicity of ovaries and uterus in female miceGuanghua Xiong, Haiyan Zhang, Yulin Peng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2016
A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced CancerLee S Rosen, Jonathan W Goldman, Alain P Algazi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 29, 2025
TIP25-243: Randomized Study Evaluating Optimal Dose, Efficacy and Safety of E7386 + Lenvatinib Versus Treatment of Physicians' Choice in Advance/Recurrent Endometrial Carcinoma Previously Treated With Anti-PD-(L)1 ImmunotherapyRamez Eskander, Jung-Yun Lee, Mansoor Mirza, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 3, 2025
Randomized study evaluating optimal dose, efficacy, and safety of E7386 plus lenvatinib versus treatment of physician's choice in advanced/recurrent endometrial carcinoma previously treated with platinum-based chemotherapy and immune checkpoint inhibitorsRamez N Eskander, Jung-Yun Lee, Mansoor Raza Mirza, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Rejoinder to Letter to the Editor "The Hazards of Period Specific and Weighted Hazard Ratios"Ray S Lin, Ji Lin, Satrajit Roychoudhury, et al.
Science (New York, N.Y.)|April 28, 2007
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variantsLaura J Scott, Karen L Mohlke, Lori L Bonnycastle, et al.
Nature Genetics|April 1, 2008
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetesEleftheria Zeggini, Laura J Scott, Richa Saxena, et al.
Pageof 2